{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:30:10Z","timestamp":1790983810835,"version":"4.1.0"},"reference-count":135,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2021,2,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Alzheimer\u2019s disease (AD) is the most common form of dementia in the elderly and this\ncomplex disorder is associated with environmental as well as genetic factors. Early-onset AD\n(EOAD) and late-onset AD (LOAD, more common) are major identified types of AD. The genetics\nof EOAD is extensively understood, with three gene variants such as APP, PSEN1, and PSEN2\nleading to the disease. Some common alleles, including APOE, are effectively associated with\nLOAD identified, but the genetics of LOAD is not clear to date. It has been accounted that about\n5-10% of EOAD patients can be explained through mutations in the three familiar genes of EOAD.\nThe APOE \u03b54 allele augmented the severity of EOAD risk in carriers, and the APOE \u03b54 allele was\nconsidered as a hallmark of EOAD. A great number of EOAD patients, who are not genetically explained,\nindicate that it is not possible to identify disease-triggering genes yet. Although several\ngenes have been identified by using the technology of next-generation sequencing in EOAD families,\nincluding SORL1, TYROBP, and NOTCH3. A number of TYROBP variants are identified\nthrough exome sequencing in EOAD patients and these TYROBP variants may increase the pathogenesis\nof EOAD. The existence of the \u03b54 allele is responsible for increasing the severity of\nEOAD. However, several \u03b54 allele carriers propose the presence of other LOAD genetic as well as\nenvironmental risk factors that are not identified yet. It is urgent to find out missing genetics of\nEOAD and LOAD etiology to discover new potential genetic facets which will assist in understanding\nthe pathological mechanism of AD. These investigations should contribute to developing a new\ntherapeutic candidate for alleviating, reversing and preventing AD. This article, based on current\nknowledge, represents the overview of the susceptible genes of EOAD, and LOAD. Next, we represent\nthe probable molecular mechanism that might elucidate the genetic etiology of AD and highlight\nthe role of massively parallel sequencing technologies for novel gene discoveries.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566523220666201123112822","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:22:52Z","timestamp":1606198972000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Molecular Genetics of Early- and Late-Onset Alzheimer\u2019s Disease"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-7840","authenticated-orcid":true,"given":"Md. Sahab","family":"Uddin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Southeast University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifa","family":"Hasana","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Farhad","family":"Hossain","sequence":"additional","affiliation":[{"name":"Pharmakon Neuroscience Research Network, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Siddiqul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Perveen","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hafeez","sequence":"additional","affiliation":[{"name":"Glocal School of Life Sciences, Glocal University, Saharanpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Md","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2174\/1568026620666200228095553","volume":"20","author":"Sharma P.","year":"2020","unstructured":"Sharma P.; Sharma A.; Fayaz F.; Wakode S.; Pottoo F.H.; Biological signatures of Alzheimer\u2019s disease. Curr Top Med Chem 2020,20(9),770-781","journal-title":"Curr Top Med Chem"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2174\/1568026620666200601161703","volume":"20","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Al Mamun A.; Rahman M.A.; Behl T.; Perveen A.; Hafeez A.; Bin-Jumah M.N.; Abdel-Daim M.M.; Ashraf G.M.; Emerging proof of protein misfolding and interactions in multifactorial Alzheimer\u2019s Disease. Curr Top Med Chem 2020,20(26),2380-90","journal-title":"Curr Top Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12068","volume":"16","year":"2020","unstructured":"2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement Alzheimer\u2019s Association2020,16,391-460","journal-title":"Alzheimers Dement"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.3390\/ijms21093272","volume":"21","author":"Kabir M.T.","year":"2020","unstructured":"Kabir M.T.; Uddin M.S.; Mamun A.A.; Jeandet P.; Aleya L.; Mansouri R.A.; Ashraf G.M.; Mathew B.; Bin-Jumah M.N.; Abdel-Daim M.M.; Combination drug therapy for the management of Alzheimer\u2019s Disease. Int J Mol Sci 2020,21(9),3272","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"Liguori I.","year":"2018","unstructured":"Liguori I.; Russo G.; Curcio F.; Bulli G.; Aran L.; Della-Morte D.; Gargiulo G.; Testa G.; Cacciatore F.; Bonaduce D.; Abete P.; Oxidative stress, aging, and diseases. Clin Interv Aging 2018,13,757-772","journal-title":"Clin Interv Aging"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"pp. 91","DOI":"10.1007\/978-981-13-9636-6_5","author":"Uddin M.S.","year":"2019","unstructured":"Uddin M.S.; Kabir M.T.; Oxidative stress in Alzheimer\u2019s disease: Molecular hallmarks of underlying vulnerability Biological, diagnostic and therapeutic advances in Alzheimer\u2019s disease Springer Singapore Available from:\n                     https:\/\/link.springer.com\/chapter\/10.1007\/978-981-13-9636-6_52019,pp. 91-115","journal-title":"Biological, diagnostic and therapeutic advances in Alzheimer\u2019s disease Springer Singapore"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"Swerdlow R.H.","year":"2018","unstructured":"Swerdlow R.H.; Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis 2018,62(3),1403-1416","journal-title":"J Alzheimers Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biology8020039","volume":"8","author":"Weidling I.","year":"2019","unstructured":"Weidling I.; Swerdlow R.H.; Mitochondrial dysfunction and stress responses in Alzheimer\u2019s disease. Biology (Basel) 2019,8(2),8","journal-title":"Biology (Basel)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"Wang R.","year":"2017","unstructured":"Wang R.; Reddy P.H.; Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease. J Alzheimers Dis 2017,57(4),1041-1048","journal-title":"J Alzheimers Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2015.12.048","volume":"1634","author":"Pallo S.P.","year":"2016","unstructured":"Pallo S.P.; DiMaio J.; Cook A.; Nilsson B.; Johnson G.V.W.; Mechanisms of tau and A\u03b2-induced excitotoxicity. Brain Res 2016,1634,119-131","journal-title":"Brain Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1759091419855541","DOI":"10.1177\/1759091419855541","volume":"11","author":"Findley C.A.","year":"2019","unstructured":"Findley C.A.; Bartke A.; Hascup K.N.; Hascup E.R.; Amyloid beta-related alterations to glutamate signaling dynamics during Alzheimer\u2019s Disease progression. ASN Neuro 2019,11,1759091419855541","journal-title":"ASN Neuro"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1007\/s12035-020-01929-y","volume":"57","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Tewari D.; Sharma G.; Kabir M.T.; Barreto G.E.; Bin-Jumah M.N.; Perveen A.; Abdel-Daim M.M.; Ashraf G.M.; Molecular mechanisms of er stress and upr in the pathogenesis of Alzheimer\u2019s Disease. Mol Neurobiol 2020,57(7),2902-2919","journal-title":"Mol Neurobiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"27625","DOI":"10.1074\/jbc.M114.582429","volume":"289","author":"Ali M.","year":"2014","unstructured":"Ali M.; Chernova T.A.; Newnam G.P.; Yin L.; Shanks J.; Karpova T.S.; Lee A.; Laur O.; Subramanian S.; Kim D.; McNally J.G.; Seyfried N.T.; Chernoff Y.O.; Wilkinson K.D.; Stress-dependent proteolytic processing of the actin assembly protein Lsb1 modulates a yeast prion. J Biol Chem 2014,289(40),27625-27639","journal-title":"J Biol Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-2009-1152","volume":"18","author":"Dong H.","year":"2009","unstructured":"Dong H.; Csernansky J.G.; Effects of stress and stress hormones on amyloid-beta protein and plaque deposition. J Alzheimers Dis 2009,18(2),459-469","journal-title":"J Alzheimers Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40142-018-0155-8","volume":"6","author":"Kamboh M.I.","year":"2018","unstructured":"Kamboh M.I.; A brief synopsis on the genetics of Alzheimer\u2019s disease. Curr Genet Med Rep 2018,6(4),133-135","journal-title":"Curr Genet Med Rep"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ncl.2017.01.005","volume":"35","author":"Mendez M.F.","year":"2017","unstructured":"Mendez M.F.; Early-onset Alzheimer disease. Neurol Clin 2017,35(2),263-281","journal-title":"Neurol Clin"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1038\/s41598-019-44848-2","volume":"9","author":"Giau V.V.","year":"2019","unstructured":"Giau V.V.; Bagyinszky E.; Yang Y.S.; Youn Y.C.; An S.S.A.; Kim S.Y.; Genetic analyses of early-onset Alzheimer\u2019s disease using next generation sequencing. Sci Rep 2019,9(1),8368","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","volume":"33","author":"Guerreiro R.J.","year":"2012","unstructured":"Guerreiro R.J.; Gustafson D.R.; Hardy J.; The genetic architecture of Alzheimer\u2019s disease: beyond APP, PSENs and APOE. Neurobiol Aging 2012,33(3),437-456","journal-title":"Neurobiol Aging"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"Goate A.","year":"1991","unstructured":"Goate A.; Chartier-Harlin M.C.; Mullan M.; Brown J.; Crawford F.; Fidani L.; Giuffra L.; Haynes A.; Irving N.; James L.; Mant R.; Newton P.; Rooke K.; Roques P.; Talbot C.; Pericak-Vance M.; Roses A.; Williamson R.; Rossor M.; Owen M.; Hardy J.; Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 1991,349(6311),704-706","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"Sherrington R.","year":"1995","unstructured":"Sherrington R.; Rogaev E.I.; Liang Y.; Rogaeva E.A.; Levesque G.; Ikeda M.; Chi H.; Lin C.; Li G.; Holman K.; Tsuda T.; Mar L.; Foncin J-F.; Bruni A.C.; Montesi M.P.; Sorbi S.; Rainero I.; Pinessi L.; Nee L.; Chumakov I.; Pollen D.; Brookes A.; Sanseau P.; Polinsky R.J.; Wasco W.; Da Silva H.A.R.; Haines J.L.; Perkicak-Vance M.A.; Tanzi R.E.; Roses A.D.; Fraser P.E.; Rommens J.M.; St George-Hyslop P.H.; Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 1995,375(6534),754-760","journal-title":"Nature"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng1095-219","volume":"11","author":"Clark R.F.","year":"1995","unstructured":"Clark R.F.; Hutton M.; Fuldner M.; Froelich S.; Karran E.; Talbot C.; Crook R.; Lendon C.; Prihar G.; He C.; Korenblat K.; Martinez A.; Wragg M.; Busfield F.; Behrens M.I.; Myers A.; Norton J.; Morris J.; Mehta N.; Pearson C.; Lincoln S.; Baker M.; Duff K.; Zehr C.; Perez-Tur J.; Houlden H.; Ruiz A.; Ossa J.; Lopera F.; Arcos M.; Madrigal L.; Collinge J.; Humphreys C.; Ashworth A.; Sarner S.; Fox N.; Harvey R.; Kennedy A.; Roques P.; Cline R.T.; Philips C.A.; Venter J.C.; Forsell L.; Axelman K.; Lilius L.; Johnston J.; Cowburn R.; Viitanen M.; Winblad B.; Kosik K.; Haltia M.; Poyhonen M.; Dickson D.; Mann D.; Neary D.; Snowden J.; Lantos P.; Lannfelt L.; Rossor M.; Roberts G.W.; Adams M.D.; Hardy J.; Goate A.; The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995,11(2),219-222","journal-title":"Nat Genet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"Rogaev E.I.","year":"1995","unstructured":"Rogaev E.I.; Sherrington R.; Rogaeva E.A.; Levesque G.; Ikeda M.; Liang Y.; Chi H.; Lin C.; Holman K.; Tsuda T.; Mar L.; Sorbi S.; Nacmias B.; Piacentini S.; Amaducci L.; Chumakov I.; Cohen D.; Lannfelt L.; Fraser P.E.; Rommens J.M.; George-Hyslop P.H.S.; Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 1995,376(6543),775-778","journal-title":"Nature"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"Levy-Lahad E.","year":"1995","unstructured":"Levy-Lahad E.; Wasco W.; Poorkaj P.; Romano D.M.; Oshima J.; Pettingell W.H.; Yu C.E.; Jondro P.D.; Schmidt S.D.; Wang K.; Crowley A.C.; Fu Y.H.; Guenette S.Y.; Galas D.; Nemens E.; Wijsman E.M.; Bird T.D.; Schellenberg G.D.; Tanzi R.E.; Candidate gene for the chromosome 1 familial alzheimer\u2019s disease locus. Science 1995,269,973-977","journal-title":"Science"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2174\/1568026620666200603112030","volume":"20","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Jakaria M.; Sobarzo-S\u00e1nchez E.; Barreto G.E.; Perveen A.; Hafeez A.; Bin-Jumah M.N.; Abdel-Daim M.M.; Ashraf G.M.; Exploring the potential of neuroproteomics in Alzheimer\u2019s disease. Curr Top Med Chem 2020,20,2263-78","journal-title":"Curr Top Med Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"Corder E.H.","year":"1993","unstructured":"Corder E.H.; Saunders A.M.; Strittmatter W.J.; Schmechel D.E.; Gaskell P.C.; Small G.W.; Roses A.D.; Haines J.L.; Pericak-Vance M.A.; Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 1993,261,921-923","journal-title":"Science"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"Strittmatter W.J.","year":"1993","unstructured":"Strittmatter W.J.; Weisgraber K.H.; Huang D.Y.; Dong L.M.; Salvesen G.S.; Pericak-Vance M.; Schmechel D.; Saunders A.M.; Goldgaber D.; Roses A.D.; Binding of human apolipoprotein E to synthetic amyloid \u03b2 peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993,90(17),8098-8102","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-016-0011-3","volume":"32","author":"Shen L.","year":"2016","unstructured":"Shen L.; Jia J.; An overview of genome-wide association studies in Alzheimer\u2019s disease. Neurosci Bull 2016,32(2),183-190","journal-title":"Neurosci Bull"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13040-014-0035-z","volume":"7","author":"Floudas C.S.","year":"2014","unstructured":"Floudas C.S.; Um N.; Kamboh M.I.; Barmada M.M.; Visweswaran S.; Identifying genetic interactions associated with late-onset Alzheimer\u2019s disease. BioData Min 2014,7(1),35","journal-title":"BioData Min"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"Bertram L.","year":"2010","unstructured":"Bertram L.; Lill C.M.; Tanzi R.E.; The genetics of Alzheimer disease: back to the future. Neuron 2010,68(2),270-281","journal-title":"Neuron"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.2880399","volume":"235","author":"St. George-Hyslop P.H.","year":"1987","unstructured":"St. George-Hyslop P.H.; Tanzi R.E.; Polinsky R.J.; Haines J.L.; Nee L.; Watkins P.C.; Myers R.H.; Feldman R.G.; Pollen D.; Drachman D.; Growdon J.; Bruni A.; Foncin J.F.; Salmon D.; Frommelt P.; Amaducci L.; Sorbi S.; Piacentini S.; Stewart G.D.; Hobbs W.J.; Conneally P.M.; Gusella J.F.; The genetic defect causing familial Alzheimer\u2019s disease maps on chromosome 21. Science 1987,235,885-890","journal-title":"Science"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ng1292-330","volume":"2","author":"St George-Hyslop P.","year":"1992","unstructured":"St George-Hyslop P.; Haines J.; Rogaev E.; Mortilla M.; Vaula G.; Pericak-Vance M.; Foncin J.F.; Montesi M.; Bruni A.; Sorbi S.; Rainero I.; Pinessi L.; Pollen D.; Polinsky R.; Nee L.; Kennedy J.; Macciardi F.; Rogaeva E.; Liang Y.; Alexandrova N.; Lukiw W.; Schlumpf K.; Tanzi R.; Tsuda T.; Farrer L.; Cantu J.M.; Duara R.; Amaducci L.; Bergamini L.; Gusella J.; Roses A.; Crapper McLachlan D.; Genetic evidence for a novel familial Alzheimer\u2019s disease locus on chromosome 14. Nat Genet 1992,2(4),330-334","journal-title":"Nat Genet"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng1292-335","volume":"2","author":"Van Broeckhoven C.","year":"1992","unstructured":"Van Broeckhoven C.; Backhovens H.; Cruts M.; De Winter G.; Bruyland M.; Cras P.; Martin J.J.; Mapping of a gene predisposing to early-onset Alzheimer\u2019s disease to chromosome 14q24.3. Nat Genet 1992,2(4),335-339","journal-title":"Nat Genet"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","volume":"5","author":"Sherrington R.","year":"1996","unstructured":"Sherrington R.; Froelich S.; Sorbi S.; Campion D.; Chi H.; Rogaeva E.A.; Levesque G.; Rogaev E.I.; Lin C.; Liang Y.; Ikeda M.; Mar L.; Brice A.; Agid Y.; Percy M.E.; Clerget-Darpoux F.; Piacentini S.; Marcon G.; Nacmias B.; Amaducci L.; Frebourg T.; Lannfelt L.; Rommens J.M.; St George-Hyslop P.H.; Alzheimer\u2019s disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 1996,5(7),985-988","journal-title":"Hum Mol Genet"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/joim.12191","volume":"275","author":"Schneider L.S.","year":"2014","unstructured":"Schneider L.S.; Mangialasche F.; Andreasen N.; Feldman H.; Giacobini E.; Jones R.; Mantua V.; Mecocci P.; Pani L.; Winblad B.; Kivipelto M.; Clinical trials and late-stage drug development for Alzheimer\u2019s disease: an appraisal from 1984 to 2014. J Intern Med 2014,275(3),251-283","journal-title":"J Intern Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0378-1119(90)90310-N","volume":"87","author":"Yoshikai S.","year":"1990","unstructured":"Yoshikai S.; ichi; Sasaki, H.; Doh-ura, K.; Furuya, H.; Sakaki, Y. Genomic organization of the human amyloid beta-protein precursor gene. Gene 1990,87,257-263","journal-title":"Gene"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","volume":"1161","author":"Matsui T.","year":"2007","unstructured":"Matsui T.; Ingelsson M.; Fukumoto H.; Ramasamy K.; Kowa H.; Frosch M.P.; Irizarry M.C.; Hyman B.T.; Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease. Brain Res 2007,1161,116-123","journal-title":"Brain Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jmb.2006.12.041","volume":"367","author":"Kong G.K.W.","year":"2007","unstructured":"Kong G.K.W.; Adams J.J.; Harris H.H.; Boas J.F.; Curtain C.C.; Galatis D.; Masters C.L.; Barnham K.J.; McKinstry W.J.; Cappai R.; Parker M.W.; Structural studies of the Alzheimer\u2019s amyloid precursor protein copper-binding domain reveal how it binds copper ions. J Mol Biol 2007,367(1),148-161","journal-title":"J Mol Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"Kang J.","year":"1987","unstructured":"Kang J.; Lemaire H.G.; Unterbeck A.; Salbaum J.M.; Masters C.L.; Grzeschik K.H.; Multhaup G.; Beyreuther K.; M\u00fcller-Hill B.; The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987,325(6106),733-736","journal-title":"Nature"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ng0993-22","volume":"5","author":"Lamb B.T.","year":"1993","unstructured":"Lamb B.T.; Sisodia S.S.; Lawler A.M.; Slunt H.H.; Kitt C.A.; Kearns W.G.; Pearson P.L.; Price D.L.; Gearhart J.D.; Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nat Genet 1993,5,22-30","journal-title":"Nat Genet"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"116974","DOI":"10.1016\/j.jns.2020.116974","volume":"416","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Tewari D.; Mamun A.A.; Mathew B.; Aleya L.; Barreto G.E.; Bin-Jumah M.N.; Abdel-Daim M.M.; Ashraf G.M.; Revisiting the role of brain and peripheral A\u03b2 in the pathogenesis of Alzheimer\u2019s disease. J Neurol Sci 2020,416,116974","journal-title":"J Neurol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/0959-4388(94)90014-0","volume":"4","author":"Selkoe D.J.","year":"1994","unstructured":"Selkoe D.J.; Amyloid \u03b2-protein precursor: new clues to the genesis of Alzheimer\u2019s disease. Curr Opin Neurobiol 1994,4(5),708-716","journal-title":"Curr Opin Neurobiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.1073\/pnas.96.20.11049","volume":"96","author":"Sinha S.","year":"1999","unstructured":"Sinha S.; Lieberburg I.; Cellular mechanisms of \u03b2-amyloid production and secretion. Proc Natl Acad Sci USA 1999,96(20),11049-11053","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","volume":"483","author":"Nunan J.","year":"2000","unstructured":"Nunan J.; Small D.H.; Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett 2000,483(1),6-10","journal-title":"FEBS Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.3390\/ijms21165858","volume":"21","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Rahman M.S.; Behl T.; Jeandet P.; Ashraf G.M.; Najda A.; Bin-Jumah M.N.; El-Seedi H.R.; Abdel-Daim M.M.; Revisiting the amyloid cascade hypothesis: From Anti-A\u03b2 therapeutics to auspicious new ways for Alzheimer\u2019s Disease. Int J Mol Sci 2020,21(16),5858","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/jphp.13244","volume":"72","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Rahman M.M.; Mathew B.; Shah M.A.; Ashraf G.M.; TV 3326 for Alzheimer\u2019s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer\u2019s-like neuropathology. J Pharm Pharmacol 2020,72(8),1001-1012","journal-title":"J Pharm Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.2174\/1381612826666200406075044","volume":"26","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Rahman M.H.; Alim M.A.; Rahman M.M.; Khatkar A.; Al Mamun A.; Rauf A.; Mathew B.; Ashraf G.M.; Exploring the multifunctional neuroprotective promise of rasagiline derivatives for multi-dysfunctional Alzheimer\u2019s Disease. Curr Pharm Des 2020,26(37),4690-4698","journal-title":"Curr Pharm Des"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","volume":"120","author":"Zhang H.","year":"2012","unstructured":"Zhang H.; Ma Q.; Zhang Y.W.; Xu H.; Proteolytic processing of Alzheimer\u2019s \u03b2-amyloid precursor protein. J Neurochem 2012,120(Suppl 1),9-21","journal-title":"J Neurochem"},{"key":"ref=48","first-page":"1","volume":"6","author":"Bhadbhade A.","year":"2012","unstructured":"Bhadbhade A.; Cheng D.W.; Amyloid precursor protein processing in Alzheimer\u2019s disease. Iran J Child Neurol 2012,6,1-4","journal-title":"Iran J Child Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/hmg\/10.16.1665","volume":"10","author":"De Jonghe C.","year":"2001","unstructured":"De Jonghe C.; Esselens C.; Kumar-Singh S.; Craessaerts K.; Serneels S.; Checler F.; Annaert W.; Van Broeckhoven C.; De Strooper B.; Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet 2001,10(16),1665-1671","journal-title":"Hum Mol Genet"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","volume":"323","author":"Di Fede G.","year":"2009","unstructured":"Di Fede G.; Catania M.; Morbin M.; Rossi G.; Suardi S.; Mazzoleni G.; Merlin M.; Giovagnoli A.R.; Prioni S.; Erbetta A.; Falcone C.; Gobbi M.; Colombo L.; Bastone A.; Beeg M.; Manzoni C.; Francescucci B.; Spagnoli A.; Cant\u00f9 L.; Del Favero E.; Levy E.; Salmona M.; Tagliavini F.; A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 2009,323,1473-1477","journal-title":"Science"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"Scheuner D.","year":"1996","unstructured":"Scheuner D.; Eckman C.; Jensen M.; Song X.; Citron M.; Suzuki N.; Bird T.D.; Hardy J.; Hutton M.; Kukull W.; Larson E.; Levy-Lahad E.; Viitanen M.; Peskind E.; Poorkaj P.; Schellenberg G.; Tanzi R.; Wasco W.; Lannfelt L.; Selkoe D.; Younkin S.; Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 1996,2(8),864-870","journal-title":"Nat Med"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11910-014-0499-8","volume":"14","author":"Ringman 1 John M","year":"2014","unstructured":"Ringman 1 John M; Goate Alison; Masters Colin L.; Cairns Nigel J; Danek Adrian; Graff-Radford Neill; Ghetti Bernardino; Morris John C; Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies. Curr Neurol Neurosci Rep 2014,14,499","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1371\/journal.pone.0035807","author":"Chen W.T.","year":"2012","unstructured":"Chen W.T.; Hong C.J.; Lin Y.T.; Chang W.H.; Huang H.T.; Liao J.Y.; Chang Y.J.; Hsieh Y.F.; Cheng C.Y.; Liu H.C.; Chen Y.R.; Cheng I.H.; Amyloid-Beta (A\u03b2) D7H Mutation Increases Oligomeric A\u03b242 and Alters Properties of A\u03b2-Zinc\/-Copper Assemblies. PLoS One 2012,7","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/emmm.201100138","volume":"3","author":"Zhou L.","year":"2011","unstructured":"Zhou L.; Brouwers N.; Benilova I.; Vandersteen A.; Mercken M.; Van Laere K.; Van Damme P.; Demedts D.; Van Leuven F.; Sleegers K.; Broersen K.; Van Broeckhoven C.; Vandenberghe R.; De Strooper B.; Amyloid precursor protein mutation E682K at the alternative \u03b2-secretase cleavage \u03b2\u2032-site increases A\u03b2 generation. EMBO Mol Med 2011,3(5),291-302","journal-title":"EMBO Mol Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/emmm.201200239","volume":"4","author":"Kaden D.","year":"2012","unstructured":"Kaden D.; Harmeier A.; Weise C.; Munter L.M.; Althoff V.; Rost B.R.; Hildebrand P.W.; Schmitz D.; Schaefer M.; Lurz R.; Skodda S.; Yamamoto R.; Arlt S.; Finckh U.; Multhaup G.; Novel APP\/A\u03b2 mutation K16N produces highly toxic heteromeric A\u03b2 oligomers. EMBO Mol Med 2012,4(7),647-659","journal-title":"EMBO Mol Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-4827(03)00117-4","volume":"287","author":"Bergman A.","year":"2003","unstructured":"Bergman A.; Religa D.; Karlstr\u00f6m H.; Laudon H.; Winblad B.; Lannfelt L.; Lundkvist J.; N\u00e4slund J.; APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer\u2019s disease mutations. Exp Cell Res 2003,287(1),1-9","journal-title":"Exp Cell Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20194757","volume":"20","author":"Giau V.V.","year":"2019","unstructured":"Giau V.V.; Bagyinszky E.; Youn Y.C.; An S.S.A.; Kim S.; \n                        APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease. Int J Mol Sci 2019,20(19),20","journal-title":"Int J Mol Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"Nilsberth C.","year":"2001","unstructured":"Nilsberth C.; Westlind-Danielsson A.; Eckman C.B.; Condron M.M.; Axelman K.; Forsell C.; Stenh C.; Luthman J.; Teplow D.B.; Younkin S.G.; N\u00e4slund J.; Lannfelt L.; The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci 2001,4(9),887-893","journal-title":"Nat Neurosci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/nbdi.1998.0202","volume":"5","author":"De Jonghe C.","year":"1998","unstructured":"De Jonghe C.; Zehr C.; Yager D.; Prada C.M.; Younkin S.; Hendriks L.; Van Broeckhoven C.; Eckman C.B.; Flemish and Dutch mutations in amyloid \u03b2 precursor protein have different effects on amyloid \u03b2 secretion. Neurobiol Dis 1998,5(4),281-286","journal-title":"Neurobiol Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.22117","volume":"33","author":"Cruts M.","year":"2012","unstructured":"Cruts M.; Theuns J.; Van Broeckhoven C.; Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat 2012,33(9),1340-1344","journal-title":"Hum Mutat"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/hmg\/9.3.325","volume":"9","author":"Theuns J.","year":"2000","unstructured":"Theuns J.; Del-Favero J.; Dermaut B.; van Duijn C.M.; Backhovens H.; Van den Broeck M.V.; Serneels S.; Corsmit E.; Van Broeckhoven C.V.; Cruts M.; Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer\u2019s disease and variable expression. Hum Mol Genet 2000,9(3),325-331","journal-title":"Hum Mol Genet"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/hmg\/6.10.1639","volume":"6","author":"Hutton M.","year":"1997","unstructured":"Hutton M.; Hardy J.; The presenilins and Alzheimer\u2019s disease. Hum Mol Genet 1997,6(10),1639-1646","journal-title":"Hum Mol Genet"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/nbdi.1999.0265","volume":"6","author":"Van Gassen G.","year":"1999","unstructured":"Van Gassen G.; De Jonghe C.; Pype S.; Van Criekinge W.; Julliams A.; Vanderhoeven I.; Woodrow S.; Beyaert R.; Huylebroeck D.; Van Broeckhoven C.; Alzheimer\u2019s disease associated presenilin 1 interacts with HC5 and ZETA, subunits of the catalytic 20S proteasome. Neurobiol Dis 1999,6(5),376-391","journal-title":"Neurobiol Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1471-4159.2003.02298.x","volume":"89","author":"Laudon H.","year":"2004","unstructured":"Laudon H.; Mathews P.M.; Karlstr\u00f6m H.; Bergman A.; Farmery M.R.; Nixon R.A.; Winblad B.; Gandy S.E.; Lendahl U.; Lundkvist J.; N\u00e4slund J.; Co-expressed presenilin 1 NTF and CTF form functional \u03b3-secretase complexes in cells devoid of full-length protein. J Neurochem 2004,89(1),44-53","journal-title":"J Neurochem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-1-4","volume":"1","author":"Vetrivel K.S.","year":"2006","unstructured":"Vetrivel K.S.; Zhang Y.W.; Xu H.; Thinakaran G.; Pathological and physiological functions of presenilins. Mol Neurodegener 2006,1,4","journal-title":"Mol Neurodegener"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2016.03.010","volume":"90","author":"Veugelen S.","year":"2016","unstructured":"Veugelen S.; Saito T.; Saido T.C.; Ch\u00e1vez-Guti\u00e9rrez L.; De Strooper B.; Familial Alzheimer\u2019s disease mutations in presenilin generate amyloidogenic A\u03b2 peptide seeds. Neuron 2016,90(2),410-416","journal-title":"Neuron"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"12186","DOI":"10.1073\/pnas.211321898","volume":"98","author":"Levitan D.","year":"2001","unstructured":"Levitan D.; Lee J.; Song L.; Manning R.; Wong G.; Parker E.; Zhang L.; PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc Natl Acad Sci USA 2001,98(21),12186-12190","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1735338100","volume":"100","author":"Schroeter E.H.","year":"2003","unstructured":"Schroeter E.H.; Ilagan M.X.G.; Brunkan A.L.; Hecimovic S.; Li Y.M.; Xu M.; Lewis H.D.; Saxena M.T.; De Strooper B.; Coonrod A.; Tomita T.; Iwatsubo T.; Moore C.L.; Goate A.; Wolfe M.S.; Shearman M.; Kopan R.; A presenilin dimer at the core of the \u03b3-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci USA 2003,100(22),13075-13080","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12640-020-00232-x","volume":"38","author":"Kabir M.T.","year":"2020","unstructured":"Kabir M.T.; Uddin M.S.; Setu J.R.; Ashraf G.M.; Bin-Jumah M.N.; Abdel-Daim M.M.; Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer\u2019s Disease. Neurotox Res 2020,38(4),833-849","journal-title":"Neurotox Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/00001756-199607080-00009","volume":"7","author":"Campion D.","year":"1996","unstructured":"Campion D.; Brice A.; Dumanchin C.; Puel M.; Baulac M.; De La Sayette V.; Hannequin D.; Duyckaerts C.; Michon A.; Martin C.; Moreau V.; Penet C.; Martinez M.; Clerget-Darpoux F.; Agid Y.; Frebourg T.; A novel presenilin 1 mutation resulting in familial Alzheimer\u2019s disease with an onset age of 29 years. Neuroreport 1996,7(10),1582-1584","journal-title":"Neuroreport"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1192\/bjp.180.2.131","volume":"180","author":"Holmes C.","year":"2002","unstructured":"Holmes C.; Genotype and phenotype in Alzheimer\u2019s disease. Br J Psychiatry 2002,180,131-134","journal-title":"Br J Psychiatry"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/sj.ejhg.5200373","volume":"7","author":"van Duijn C.M.","year":"1999","unstructured":"van Duijn C.M.; Cruts M.; Theuns J.; Van Gassen G.; Backhovens H.; van den Broeck M.; Wehnert A.; Serneels S.; Hofman A.; Van Broeckhoven C.; Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer\u2019s disease in a population-based sample. Eur J Hum Genet 1999,7(7),801-806","journal-title":"Eur J Hum Genet"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/hmg\/ddg098","volume":"12","author":"Theuns J.","year":"2003","unstructured":"Theuns J.; Remacle J.; Killick R.; Corsmit E.; Huylebroeck D.; Cruts M.; Van Broeckhoven C.; Alzheimer-associated c allele of the promoter polymorphism \u00e022c>t causes a critical neuron-specific decrease of Presenilin 1 expression. Hum Mol Genet 2003,12(8),869-77","journal-title":"Hum Mol Genet"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/WAD.0b013e3181732399","volume":"22","author":"Rudzinski L.A.","year":"2008","unstructured":"Rudzinski L.A.; Fletcher R.M.; Dickson D.W.; Crook R.; Hutton M.L.; Adamson J.; Graff-Radford N.R.; Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Dis Assoc Disord 2008,22(3),299-307","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1136\/jmg.39.2.e2","volume":"39","author":"Jacquemont M.L.","year":"2002","unstructured":"Jacquemont M.L.; Campion D.; Hahn V.; Tallaksen C.; Frebourg T.; Brice A.; Durr A.; Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer\u2019s disease. J Med Genet 2002,39(2),E2","journal-title":"J Med Genet"},{"key":"ref=76","unstructured":"Mutation: PSEN-1 ALZFORUMAvailable at:\n                     https:\/\/www.alzforum.org\/mutations\/psen-1"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1531-8249(200009)48:3<376::AID-ANA13>3.0.CO;2-U","volume":"48","author":"Lippa 1 C F","year":"2000","unstructured":"Lippa 1 C F; Swearer J M.; Kane K J.; Nochlin D.; Bird T D.; Ghetti B.; Nee L E.; George-Hyslop P St.; Pollen D A.; Drachman D A; Familial Alzheimer\u2019s disease: site of mutation influences clinical phenotype. Ann Neurol 2000,48(3),376-9","journal-title":"Ann Neurol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1073\/pnas.1618657114","volume":"114","author":"Sun L.","year":"2017","unstructured":"Sun L.; Zhou R.; Yang G.; Shi Y.; Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase. Proc Natl Acad Sci USA 2017,114(4),E476-E485","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"Borchelt D.R.","year":"1996","unstructured":"Borchelt D.R.; Thinakaran G.; Eckman C.B.; Lee M.K.; Davenport F.; Ratovitsky T.; Prada C.M.; Kim G.; Seekins S.; Yager D.; Slunt H.H.; Wang R.; Seeger M.; Levey A.I.; Gandy S.E.; Copeland N.G.; Jenkins N.A.; Price D.L.; Younkin S.G.; Sisodia S.S.; Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo. Neuron 1996,17(5),1005-1013","journal-title":"Neuron"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"28176","DOI":"10.1074\/jbc.M803159200","volume":"283","author":"Jan A.","year":"2008","unstructured":"Jan A.; Gokce O.; Luthi-Carter R.; Lashuel H.A.; The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-\u03b2 aggregation, fibrillogenesis, and toxicity. J Biol Chem 2008,283(42),28176-28189","journal-title":"J Biol Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"e35133","DOI":"10.1371\/journal.pone.0035133","volume":"7","author":"Cacquevel M.","year":"2012","unstructured":"Cacquevel M.; Aeschbach L.; Houacine J.; Fraering P.C.; Alzheimer\u2019s disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified \u03b3-secretase complexes. PLoS One 2012,7(4),e35133","journal-title":"PLoS One"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"Bentahir M.","year":"2006","unstructured":"Bentahir M.; Nyabi O.; Verhamme J.; Tolia A.; Horr\u00e9 K.; Wiltfang J.; Esselmann H.; De Strooper B.; Presenilin clinical mutations can affect \u03b3-secretase activity by different mechanisms. J Neurochem 2006,96(3),732-742","journal-title":"J Neurochem"},{"key":"ref=83","first-page":"1163","volume":"10","author":"Cai Y.","year":"2015","unstructured":"Cai Y.; An S.S.A.; Kim S.; Mutations in presenilin 2 and its implications in Alzheimer\u2019s disease and other dementia-associated disorders. Clin Interv Aging 2015,10,1163-1172","journal-title":"Clin Interv Aging"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.7638621","volume":"269","author":"Levy-Lahad E.","year":"1995","unstructured":"Levy-Lahad E.; Wijsman E.M.; Nemens E.; Anderson L.; Goddard K.A.B.; Weber J.L.; Bird T.D.; Schellenberg G.D.; A familial Alzheimer\u2019s disease locus on Chromosome I.  Science 1995,269,970-973","journal-title":"Science"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/00001756-199602290-00029","volume":"7","author":"Hutton M.","year":"1996","unstructured":"Hutton M.; Busfield F.; Wragg M.; Crook R.; Perez-Tur J.; Clark R.F.; Prihar G.; Talbot C.; Phillips H.; Wright K.; Baker M.; Lendon C.; Duff K.; Martinez A.; Houlden H.; Nichols A.; Karran E.; Roberts G.; Roques P.; Rossor M.; Venter J.C.; Adams M.D.; Cline R.T.; Phillips C.A.; Goate A.; Hardy J.; Goate A.; Complete analysis of the presenilin 1 gene in early onset Alzheimer\u2019s disease. Neuroreport 1996,7(3),801-805","journal-title":"Neuroreport"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3329\/jemc.v4i1.18069","volume":"4","author":"Ahmed S.S.","year":"2014","unstructured":"Ahmed S.S.; Khan M.A.H.; Laila T.R.; Treatment and prevention of common complications of chronic kidney disease. J Enam Med Coll 2014,4,45-55","journal-title":"J Enam Med Coll"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"e15743","DOI":"10.1371\/journal.pone.0015743","volume":"5","author":"Jayadev S.","year":"2010","unstructured":"Jayadev S.; Case A.; Eastman A.J.; Nguyen H.; Pollak J.; Wiley J.C.; M\u00f6ller T.; Morrison R.S.; Garden G.A.; Presenilin 2 is the predominant \u03b3-secretase in microglia and modulates cytokine release. PLoS One 2010,5(12),e15743","journal-title":"PLoS One"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nbd.2014.07.011","volume":"71","author":"Pensalfini A.","year":"2014","unstructured":"Pensalfini A.; Albay R.; Rasool S.; Wu J.W.; Hatami A.; Arai H.; Margol L.; Milton S.; Poon W.W.; Corrada M.M.; Kawas C.H.; Glabe C.G.; Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis 2014,71,53-61","journal-title":"Neurobiol Dis"},{"key":"ref=89","first-page":"16","volume":"139","author":"Samra A.","year":"2012","unstructured":"Samra A.; Ramtahal J.; Recurrent subacute visual loss presenting in a 52-year-old Caucasian woman with chronic relapsing inflammatory optic neuropathy: a case report. Brain 2012,139,16-17","journal-title":"Brain"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2377-14-105","volume":"14","author":"Youn Y.C.","year":"2014","unstructured":"Youn Y.C.; Bagyinszky E.; Kim H.; Choi B.O.; An S.S.; Kim S.; Probable novel PSEN2 Val214Leu mutation in Alzheimer\u2019s disease supported by structural prediction. BMC Neurol 2014,14,105","journal-title":"BMC Neurol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/bmm.09.92","volume":"4","author":"Ryan N.S.","year":"2010","unstructured":"Ryan N.S.; Rossor M.N.; Correlating familial Alzheimer\u2019s disease gene mutations with clinical phenotype. Biomarkers Med 2010,4(1),99-112","journal-title":"Biomarkers Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","volume":"92","author":"Walker E.S.","year":"2005","unstructured":"Walker E.S.; Martinez M.; Brunkan A.L.; Goate A.; Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in Abeta 42\/40 ratios. J Neurochem 2005,92(2),294-301","journal-title":"J Neurochem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nbd.2003.11.002","volume":"15","author":"Zatti G.","year":"2004","unstructured":"Zatti G.; Ghidoni R.; Barbiero L.; Binetti G.; Pozzan T.; Fasolato C.; Pizzo P.; The presenilin 2 M239I mutation associated with familial Alzheimer\u2019s disease reduces Ca2+ release from intracellular stores. Neurobiol Dis 2004,15(2),269-278","journal-title":"Neurobiol Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ceca.2006.03.002","volume":"39","author":"Zatti G.","year":"2006","unstructured":"Zatti G.; Burgo A.; Giacomello M.; Barbiero L.; Ghidoni R.; Sinigaglia G.; Florean C.; Bagnoli S.; Binetti G.; Sorbi S.; Pizzo P.; Fasolato C.; Presenilin mutations linked to familial Alzheimer\u2019s disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 2006,39(6),539-550","journal-title":"Cell Calcium"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"Gatz M.","year":"2006","unstructured":"Gatz M.; Reynolds C.A.; Fratiglioni L.; Johansson B.; Mortimer J.A.; Berg S.; Fiske A.; Pedersen N.L.; Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006,63(2),168-174","journal-title":"Arch Gen Psychiatry"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"Saunders A.M.","year":"1993","unstructured":"Saunders A.M.; Strittmatter W.J.; Schmechel D.; George-Hyslop P.H.; Pericak-Vance M.A.; Joo S.H.; Rosi B.L.; Gusella J.F.; Crapper-MacLachlan D.R.; Alberts M.J.; Hulette C.; Crain B.; Goldgaber D.; Roses A.D.; Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 1993,43(8),1467-1472","journal-title":"Neurology"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"254954","DOI":"10.1155\/2013\/254954","volume":"2013","author":"Ridge P.G.","year":"2013","unstructured":"Ridge P.G.; Ebbert M.T.W.; Kauwe J.S.K.; Genetics of Alzheimer\u2019s disease. BioMed Res Int 2013,2013,254954","journal-title":"BioMed Res Int"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.aohep.2019.07.011","volume":"19","author":"Nascimento J.C.R.","year":"2020","unstructured":"Nascimento J.C.R.; Matos G.A.; Pereira L.C.; Mour\u00e3o A.E.C.C.B.; Sampaio A.M.; Ori\u00e1 R.B.; Toniutto P.; Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review. Ann Hepatol 2020,19(1),24-30","journal-title":"Ann Hepatol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","volume":"56","author":"Uddin M.S.","year":"2019","unstructured":"Uddin M.S.; Kabir M.T.; Al Mamun A.; Abdel-Daim M.M.; Barreto G.E.; Ashraf G.M.; APOE and Alzheimer\u2019s disease: Evidence mounts that targeting APOE4 may combat Alzheimer\u2019s pathogenesis. Mol Neurobiol 2019,56(4),2450-2465","journal-title":"Mol Neurobiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","volume":"74","author":"Neu S.C.","year":"2017","unstructured":"Neu S.C.; Pa J.; Kukull W.; Beekly D.; Kuzma A.; Gangadharan P.; Wang L.S.; Romero K.; Arneric S.P.; Redolfi A.; Orlandi D.; Frisoni G.B.; Au R.; Devine S.; Auerbach S.; Espinosa A.; Boada M.; Ruiz A.; Johnson S.C.; Koscik R.; Wang J.J.; Hsu W.C.; Chen Y.L.; Toga A.W.; Apolipoprotein E.; Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis. JAMA Neurol 2017,74(10),1178-1189","journal-title":"JAMA Neurol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"5086250","DOI":"10.1155\/2020\/5086250","volume":"2020","author":"Mamun A.A.","year":"2020","unstructured":"Mamun A.A.; Uddin M.S.; Bin Bashar M.F.; Zaman S.; Begum Y.; Bulbul I.J.; Islam M.S.; Sarwar M.S.; Mathew B.; Amran M.S.; Md Ashraf G.; Bin-Jumah M.N.; Mousa S.A.; Abdel-Daim M.M.; Molecular insight into the therapeutic promise of targeting APOE4 for Alzheimer\u2019s disease. Oxid Med Cell Longev 2020,2020,5086250","journal-title":"Oxid Med Cell Longev"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"Corder E.H.","year":"1994","unstructured":"Corder E.H.; Saunders A.M.; Risch N.J.; Strittmatter W.J.; Schmechel D.E.; Gaskell P.C.; Rimmler J.B.; Locke P.A.; Conneally P.M.; Schmader K.E.; Small G.W.; Roses A.D.; Haines J.L.; Pericak-Vance M.A.; Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994,7(2),180-184","journal-title":"Nat Genet"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"Deane R.","year":"2008","unstructured":"Deane R.; Sagare A.; Hamm K.; Parisi M.; Lane S.; Finn M.B.; Holtzman D.M.; Zlokovic B.V.; Apo E.; apoE isoform-specific disruption of amyloid \u03b2 peptide clearance from mouse brain. J Clin Invest 2008,118(12),4002-4013","journal-title":"J Clin Invest"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"Lambert J.C.","year":"2013","unstructured":"Lambert J.C.; Ibrahim-Verbaas C.A.; Harold D.; Naj A.C.; Sims R.; Bellenguez C.; DeStafano A.L.; Bis J.C.; Beecham G.W.; Grenier-Boley B.; Russo G.; Thorton-Wells T.A.; Jones N.; Smith A.V.; Chouraki V.; Thomas C.; Ikram M.A.; Zelenika D.; Vardarajan B.N.; Kamatani Y.; Lin C.F.; Gerrish A.; Schmidt H.; Kunkle B.; Dunstan M.L.; Ruiz A.; Bihoreau M.T.; Choi S.H.; Reitz C.; Pasquier F.; Cruchaga C.; Craig D.; Amin N.; Berr C.; Lopez O.L.; De Jager P.L.; Deramecourt V.; Johnston J.A.; Evans D.; Lovestone S.; Letenneur L.; Mor\u00f3n F.J.; Rubinsztein D.C.; Eiriksdottir G.; Sleegers K.; Goate A.M.; Fi\u00e9vet N.; Huentelman M.W.; Gill M.; Brown K.; Kamboh M.I.; Keller L.; Barberger-Gateau P.; McGuiness B.; Larson E.B.; Green R.; Myers A.J.; Dufouil C.; Todd S.; Wallon D.; Love S.; Rogaeva E.; Gallacher J.; St George-Hyslop P.; Clarimon J.; Lleo A.; Bayer A.; Tsuang D.W.; Yu L.; Tsolaki M.; Boss\u00f9 P.; Spalletta G.; Proitsi P.; Collinge J.; Sorbi S.; Sanchez-Garcia F.; Fox N.C.; Hardy J.; Deniz Naranjo M.C.; Bosco P.; Clarke R.; Brayne C.; Galimberti D.; Mancuso M.; Matthews F.; Moebus S.; Mecocci P.; Del Zompo M.; Maier W.; Hampel H.; Pilotto A.; Bullido M.; Panza F.; Caffarra P.; Nacmias B.; Gilbert J.R.; Mayhaus M.; Lannefelt L.; Hakonarson H.; Pichler S.; Carrasquillo M.M.; Ingelsson M.; Beekly D.; Alvarez V.; Zou F.; Valladares O.; Younkin S.G.; Coto E.; Hamilton-Nelson K.L.; Gu W.; Razquin C.; Pastor P.; Mateo I.; Owen M.J.; Faber K.M.; Jonsson P.V.; Combarros O.; O\u2019Donovan M.C.; Cantwell L.B.; Soininen H.; Blacker D.; Mead S.; Mosley T.H.; Bennett D.A.; Harris T.B.; Fratiglioni L.; Holmes C.; de Bruijn R.F.; Passmore P.; Montine T.J.; Bettens K.; Rotter J.I.; Brice A.; Morgan K.; Foroud T.M.; Kukull W.A.; Hannequin D.; Powell J.F.; Nalls M.A.; Ritchie K.; Lunetta K.L.; Kauwe J.S.; Boerwinkle E.; Riemenschneider M.; Boada M.; Hiltuenen M.; Martin E.R.; Schmidt R.; Rujescu D.; Wang L.S.; Dartigues J.F.; Mayeux R.; Tzourio C.; Hofman A.; N\u00f6then M.M.; Graff C.; Psaty B.M.; Jones L.; Haines J.L.; Holmans P.A.; Lathrop M.; Pericak-Vance M.A.; Launer L.J.; Farrer L.A.; van Duijn C.M.; Van Broeckhoven C.; Moskvina V.; Seshadri S.; Williams J.; Schellenberg G.D.; Amouyel P.; Rotter J.I.; Brice A.; Nalls M.A.; Kauwe J.S.K.; Boerwinkle E.; Schmidt R.; Rujescu D.; Tzourio C.; N\u00f6then M.M.; Launer L.J.; Seshadri S.; Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 2013,45(12),1452-1458","journal-title":"Nat Genet"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"Genin E.","year":"2011","unstructured":"Genin E.; Hannequin D.; Wallon D.; Sleegers K.; Hiltunen M.; Combarros O.; Bullido M.J.; Engelborghs S.; De Deyn P.; Berr C.; Pasquier F.; Dubois B.; Tognoni G.; Fi\u00e9vet N.; Brouwers N.; Bettens K.; Arosio B.; Coto E.; Del Zompo M.; Mateo I.; Epelbaum J.; Frank-Garcia A.; Helisalmi S.; Porcellini E.; Pilotto A.; Forti P.; Ferri R.; Scarpini E.; Siciliano G.; Solfrizzi V.; Sorbi S.; Spalletta G.; Valdivieso F.; Veps\u00e4l\u00e4inen S.; Alvarez V.; Bosco P.; Mancuso M.; Panza F.; Nacmias B.; Boss\u00f9 P.; Hanon O.; Piccardi P.; Annoni G.; Seripa D.; Galimberti D.; Licastro F.; Soininen H.; Dartigues J.F.; Kamboh M.I.; Van Broeckhoven C.; Lambert J.C.; Amouyel P.; Campion D.; APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011,16(9),903-907","journal-title":"Mol Psychiatry"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2016.07.028","volume":"48","author":"Pottier C.","year":"2016","unstructured":"Pottier C.; Ravenscroft T.A.; Brown P.H.; Finch N.A.; Baker M.; Parsons M.; Asmann Y.W.; Ren Y.; Christopher E.; Levitch D.; van Blitterswijk M.; Cruchaga C.; Campion D.; Nicolas G.; Richard A.C.; Guerreiro R.; Bras J.T.; Zuchner S.; Gonzalez M.A.; Bu G.; Younkin S.; Knopman D.S.; Josephs K.A.; Parisi J.E.; Petersen R.C.; Ertekin-Taner N.; Graff-Radford N.R.; Boeve B.F.; Dickson D.W.; Rademakers R.; TYROBP genetic variants in early-onset Alzheimer\u2019s disease. Neurobiol Aging 2016,48,9-15","journal-title":"Neurobiol Aging"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/mp.2015.121","volume":"21","author":"Nicolas G.","year":"2016","unstructured":"Nicolas G.; Charbonnier C.; Wallon D.; Quenez O.; Bellenguez C.; Grenier-Boley B.; Rousseau S.; Richard A.C.; Rovelet-Lecrux A.; Le Guennec K.; Bacq D.; Garnier J.G.; Olaso R.; Boland A.; Meyer V.; Deleuze J.F.; Amouyel P.; Munter H.M.; Bourque G.; Lathrop M.; Frebourg T.; Redon R.; Letenneur L.; Dartigues J.F.; G\u00e9nin E.; Lambert J.C.; Hannequin D.; Campion D.; SORL1 rare variants: a major risk factor for familial early-onset Alzheimer\u2019s disease. Mol Psychiatry CNR-MAJ collaborators2016,21(6),831-836","journal-title":"Mol Psychiatry"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"17-23","DOI":"10.1016\/j.neurobiolaging.2011.10.009","volume":"33","author":"Guerreiro R.J.","year":"2012","unstructured":"Guerreiro R.J.; Lohmann E.; Kinsella E.; Br\u00e1s J.M.; Luu N.; Gurunlian N.; Dursun B.; Bilgic B.; Santana I.; Hanagasi H.; Gurvit H.; Gibbs J.R.; Oliveira C.; Emre M.; Singleton A.; Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer\u2019s disease. Neurobiol Aging 2012,33(5),17-23","journal-title":"Neurobiol Aging"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/mp.2012.15","volume":"17","author":"Pottier C.","year":"2012","unstructured":"Pottier C.; Hannequin D.; Coutant S.; Rovelet-Lecrux A.; Wallon D.; Rousseau S.; Legallic S.; Paquet C.; Bombois S.; Pariente J.; Thomas-Anterion C.; Michon A.; Croisile B.; Etcharry-Bouyx F.; Berr C.; Dartigues J.F.; Amouyel P.; Dauchel H.; Boutoleau-Bretonni\u00e8re C.; Thauvin C.; Frebourg T.; Lambert J.C.; Campion D.; High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry PHRC GMAJ Collaborators2012,17(9),875-879","journal-title":"Mol Psychiatry"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","volume":"12","author":"Bettens K.","year":"2013","unstructured":"Bettens K.; Sleegers K.; Van Broeckhoven C.; Genetic insights in Alzheimer\u2019s disease. Lancet Neurol 2013,12(1),92-104","journal-title":"Lancet Neurol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.mp.4001772","volume":"11","author":"Sill\u00e9n A.","year":"2006","unstructured":"Sill\u00e9n A.; Forsell C.; Lilius L.; Axelman K.; Bj\u00f6rk B.F.; Onkamo P.; Kere J.; Winblad B.; Graff C.; Genome scan on Swedish Alzheimer\u2019s disease families. Mol Psychiatry 2006,11(2),182-186","journal-title":"Mol Psychiatry"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/sj.ejhg.5201946","volume":"16","author":"Sill\u00e9n A.","year":"2008","unstructured":"Sill\u00e9n A.; Andrade J.; Lilius L.; Forsell C.; Axelman K.; Odeberg J.; Winblad B.; Graff C.; Expanded high-resolution genetic study of 109 Swedish families with Alzheimer\u2019s disease. Eur J Hum Genet 2008,16(2),202-208","journal-title":"Eur J Hum Genet"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000323808","volume":"31","author":"Sill\u00e9n A.","year":"2011","unstructured":"Sill\u00e9n A.; Brohede J.; Forsell C.; Lilius L.; Andrade J.; Odeberg J.; Kimura T.; Winblad B.; Graff C.; Linkage analysis of autopsy--confirmed familial Alzheimer disease supports an Alzheimer disease locus in 8q24. Dement Geriatr Cogn Disord 2011,31(2),109-118","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/jmg.2006.043000","volume":"43","author":"Giedraitis V.","year":"2006","unstructured":"Giedraitis V.; Hedlund M.; Skoglund L.; Blom E.; Ingvast S.; Brundin R.; Lannfelt L.; Glaser A.; New Alzheimer\u2019s disease locus on chromosome 8. J Med Genet 2006,43(12),931-935","journal-title":"J Med Genet"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1086\/491749","volume":"77","author":"Rademakers R.","year":"2005","unstructured":"Rademakers R.; Cruts M.; Sleegers K.; Dermaut B.; Theuns J.; Aulchenko Y.; Weckx S.; De Pooter T.; Van den Broeck M.; Corsmit E.; De Rijk P.; Del-Favero J.; van Swieten J.; van Duijn C.M.; Van Broeckhoven C.; Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am J Hum Genet 2005,77(4),643-652","journal-title":"Am J Hum Genet"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.2225","volume":"16","author":"Van Broeckhoven C.","year":"2010","unstructured":"Van Broeckhoven C.; The future of genetic research on neurodegeneration. Nat Med 2010,16(11),1215-1217","journal-title":"Nat Med"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1469-1809.2009.00546.x","volume":"73","author":"Valdmanis P.N.","year":"2009","unstructured":"Valdmanis P.N.; Belzil V.V.; Lee J.; Dion P.A.; St-Onge J.; Hince P.; Funalot B.; Couratier P.; Clavelou P.; Camu W.; Rouleau G.A.; A mutation that creates a pseudoexon in SOD1 causes familial ALS. Ann Hum Genet 2009,73(Pt 6),652-657","journal-title":"Ann Hum Genet"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"Cruts M.","year":"2006","unstructured":"Cruts M.; Gijselinck I.; van der Zee J.; Engelborghs S.; Wils H.; Pirici D.; Rademakers R.; Vandenberghe R.; Dermaut B.; Martin J.J.; van Duijn C.; Peeters K.; Sciot R.; Santens P.; De Pooter T.; Mattheijssens M.; Van den Broeck M.; Cuijt I.; Vennekens K.; De Deyn P.P.; Kumar-Singh S.; Van Broeckhoven C.; Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006,442(7105),920-924","journal-title":"Nature"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2019.0250","volume":"76","author":"Heckman M.G.","year":"2019","unstructured":"Heckman M.G.; Brennan R.R.; Labb\u00e9 C.; Soto A.I.; Koga S.; DeTure M.A.; Murray M.E.; Petersen R.C.; Boeve B.F.; van Gerpen J.A.; Uitti R.J.; Wszolek Z.K.; Rademakers R.; Dickson D.W.; Ross O.A.; Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol 2019,76(6),710-717","journal-title":"JAMA Neurol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/mp.2013.24","volume":"18","author":"Nho K.","year":"2013","unstructured":"Nho K.; Corneveaux J.J.; Kim S.; Lin H.; Risacher S.L.; Shen L.; Swaminathan S.; Ramanan V.K.; Liu Y.; Foroud T.; Inlow M.H.; Siniard A.L.; Reiman R.A.; Aisen P.S.; Petersen R.C.; Green R.C.; Jack C.R.; Weiner M.W.; Baldwin C.T.; Lunetta K.; Farrer L.A.; Furney S.J.; Lovestone S.; Simmons A.; Mecocci P.; Vellas B.; Tsolaki M.; Kloszewska I.; Soininen H.; McDonald B.C.; Farlow M.R.; Ghetti B.; Huentelman M.J.; Saykin A.J.; Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry 2013,18(7),781-787","journal-title":"Mol Psychiatry"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"Harold D.","year":"2009","unstructured":"Harold D.; Abraham R.; Hollingworth P.; Sims R.; Gerrish A.; Hamshere M.L.; Pahwa J.S.; Moskvina V.; Dowzell K.; Williams A.; Jones N.; Thomas C.; Stretton A.; Morgan A.R.; Lovestone S.; Powell J.; Proitsi P.; Lupton M.K.; Brayne C.; Rubinsztein D.C.; Gill M.; Lawlor B.; Lynch A.; Morgan K.; Brown K.S.; Passmore P.A.; Craig D.; McGuinness B.; Todd S.; Holmes C.; Mann D.; Smith A.D.; Love S.; Kehoe P.G.; Hardy J.; Mead S.; Fox N.; Rossor M.; Collinge J.; Maier W.; Jessen F.; Sch\u00fcrmann B.; Heun R.; van den Bussche H.; Heuser I.; Kornhuber J.; Wiltfang J.; Dichgans M.; Fr\u00f6lich L.; Hampel H.; H\u00fcll M.; Rujescu D.; Goate A.M.; Kauwe J.S.K.; Cruchaga C.; Nowotny P.; Morris J.C.; Mayo K.; Sleegers K.; Bettens K.; Engelborghs S.; De Deyn P.P.; Van Broeckhoven C.; Livingston G.; Bass N.J.; Gurling H.; McQuillin A.; Gwilliam R.; Deloukas P.; Al-Chalabi A.; Shaw C.E.; Tsolaki M.; Singleton A.B.; Guerreiro R.; M\u00fchleisen T.W.; N\u00f6then M.M.; Moebus S.; J\u00f6ckel K.H.; Klopp N.; Wichmann H.E.; Carrasquillo M.M.; Pankratz V.S.; Younkin S.G.; Holmans P.A.; O\u2019Donovan M.; Owen M.J.; Williams J.; Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 2009,41(10),1088-1093","journal-title":"Nat Genet"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"Hollingworth P.","year":"2011","unstructured":"Hollingworth P.; Harold D.; Sims R.; Gerrish A.; Lambert J.C.; Carrasquillo M.M.; Abraham R.; Hamshere M.L.; Pahwa J.S.; Moskvina V.; Dowzell K.; Jones N.; Stretton A.; Thomas C.; Richards A.; Ivanov D.; Widdowson C.; Chapman J.; Lovestone S.; Powell J.; Proitsi P.; Lupton M.K.; Brayne C.; Rubinsztein D.C.; Gill M.; Lawlor B.; Lynch A.; Brown K.S.; Passmore P.A.; Craig D.; McGuinness B.; Todd S.; Holmes C.; Mann D.; Smith A.D.; Beaumont H.; Warden D.; Wilcock G.; Love S.; Kehoe P.G.; Hooper N.M.; Vardy E.R.L.C.; Hardy J.; Mead S.; Fox N.C.; Rossor M.; Collinge J.; Maier W.; Jessen F.; R\u00fcther E.; Sch\u00fcrmann B.; Heun R.; K\u00f6lsch H.; van den Bussche H.; Heuser I.; Kornhuber J.; Wiltfang J.; Dichgans M.; Fr\u00f6lich L.; Hampel H.; Gallacher J.; H\u00fcll M.; Rujescu D.; Giegling I.; Goate A.M.; Kauwe J.S.K.; Cruchaga C.; Nowotny P.; Morris J.C.; Mayo K.; Sleegers K.; Bettens K.; Engelborghs S.; De Deyn P.P.; Van Broeckhoven C.; Livingston G.; Bass N.J.; Gurling H.; McQuillin A.; Gwilliam R.; Deloukas P.; Al-Chalabi A.; Shaw C.E.; Tsolaki M.; Singleton A.B.; Guerreiro R.; M\u00fchleisen T.W.; N\u00f6then M.M.; Moebus S.; J\u00f6ckel K.H.; Klopp N.; Wichmann H.E.; Pankratz V.S.; Sando S.B.; Aasly J.O.; Barcikowska M.; Wszolek Z.K.; Dickson D.W.; Graff-Radford N.R.; Petersen R.C.; van Duijn C.M.; Breteler M.M.B.; Ikram M.A.; DeStefano A.L.; Fitzpatrick A.L.; Lopez O.; Launer L.J.; Seshadri S.; Berr C.; Campion D.; Epelbaum J.; Dartigues J.F.; Tzourio C.; Alp\u00e9rovitch A.; Lathrop M.; Feulner T.M.; Friedrich P.; Riehle C.; Krawczak M.; Schreiber S.; Mayhaus M.; Nicolhaus S.; Wagenpfeil S.; Steinberg S.; Stefansson H.; Stefansson K.; Snaedal J.; Bj\u00f6rnsson S.; Jonsson P.V.; Chouraki V.; Genier-Boley B.; Hiltunen M.; Soininen H.; Combarros O.; Zelenika D.; Delepine M.; Bullido M.J.; Pasquier F.; Mateo I.; Frank-Garcia A.; Porcellini E.; Hanon O.; Coto E.; Alvarez V.; Bosco P.; Siciliano G.; Mancuso M.; Panza F.; Solfrizzi V.; Nacmias B.; Sorbi S.; Boss\u00f9 P.; Piccardi P.; Arosio B.; Annoni G.; Seripa D.; Pilotto A.; Scarpini E.; Galimberti D.; Brice A.; Hannequin D.; Licastro F.; Jones L.; Holmans P.A.; Jonsson T.; Riemenschneider M.; Morgan K.; Younkin S.G.; Owen M.J.; O\u2019Donovan M.; Amouyel P.; Williams J.; Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 2011,43(5),429-435","journal-title":"Nat Genet"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"Seshadri S.","year":"2010","unstructured":"Seshadri S.; Fitzpatrick A.L.; Ikram M.A.; DeStefano A.L.; Gudnason V.; Boada M.; Bis J.C.; Smith A.V.; Carassquillo M.M.; Lambert J.C.; Harold D.; Schrijvers E.M.C.; Ramirez-Lorca R.; Debette S.; Longstreth W.T.; Janssens A.C.J.W.; Pankratz V.S.; Dartigues J.F.; Hollingworth P.; Aspelund T.; Hernandez I.; Beiser A.; Kuller L.H.; Koudstaal P.J.; Dickson D.W.; Tzourio C.; Abraham R.; Antunez C.; Du Y.; Rotter J.I.; Aulchenko Y.S.; Harris T.B.; Petersen R.C.; Berr C.; Owen M.J.; Lopez-Arrieta J.; Varadarajan B.N.; Becker J.T.; Rivadeneira F.; Nalls M.A.; Graff-Radford N.R.; Campion D.; Auerbach S.; Rice K.; Hofman A.; Jonsson P.V.; Schmidt H.; Lathrop M.; Mosley T.H.; Au R.; Psaty B.M.; Uitterlinden A.G.; Farrer L.A.; Lumley T.; Ruiz A.; Williams J.; Amouyel P.; Younkin S.G.; Wolf P.A.; Launer L.J.; Lopez O.L.; van Duijn C.M.; Breteler M.M.B.; Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA CHARGE Consortium2010,303(18),1832-1840","journal-title":"JAMA"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"Karch C.M.","year":"2015","unstructured":"Karch C.M.; Goate A.M.; Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 2015,77(1),43-51","journal-title":"Biol Psychiatry"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2990.2011.01181.x","volume":"37","author":"Morgan K.","year":"2011","unstructured":"Morgan K.; The three new pathways leading to Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 2011,37(4),353-357","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"Bemiller S.M.","year":"2017","unstructured":"Bemiller S.M.; McCray T.J.; Allan K.; Formica S.V.; Xu G.; Wilson G.; Kokiko-Cochran O.N.; Crish S.D.; Lasagna-Reeves C.A.; Ransohoff R.M.; Landreth G.E.; Lamb B.T.; TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener 2017,12(1),74","journal-title":"Mol Neurodegener"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"Jonsson T.","year":"2013","unstructured":"Jonsson T.; Stefansson H.; Steinberg S.; Jonsdottir I.; Jonsson P.V.; Snaedal J.; Bjornsson S.; Huttenlocher J.; Levey A.I.; Lah J.J.; Rujescu D.; Hampel H.; Giegling I.; Andreassen O.A.; Engedal K.; Ulstein I.; Djurovic S.; Ibrahim-Verbaas C.; Hofman A.; Ikram M.A.; van Duijn C.M.; Thorsteinsdottir U.; Kong A.; Stefansson K.; Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 2013,368(2),107-116","journal-title":"N Engl J Med"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"Steinberg S.","year":"2015","unstructured":"Steinberg S.; Stefansson H.; Jonsson T.; Johannsdottir H.; Ingason A.; Helgason H.; Sulem P.; Magnusson O.T.; Gudjonsson S.A.; Unnsteinsdottir U.; Kong A.; Helisalmi S.; Soininen H.; Lah J.J.; Aarsland D.; Fladby T.; Ulstein I.D.; Djurovic S.; Sando S.B.; White L.R.; Knudsen G-P.; Westlye L.T.; Selb\u00e6k G.; Giegling I.; Hampel H.; Hiltunen M.; Levey A.I.; Andreassen O.A.; Rujescu D.; Jonsson P.V.; Bjornsson S.; Snaedal J.; Stefansson K.; Stefansson K.; Loss-of--function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet DemGene2015,47(5),445-447","journal-title":"Nat Genet"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(15)00133-7","volume":"14","author":"Cuyvers E.","year":"2015","unstructured":"Cuyvers E.; De Roeck A.; Van den Bossche T.; Van Cauwenberghe C.; Bettens K.; Vermeulen S.; Mattheijssens M.; Peeters K.; Engelborghs S.; Vandenbulcke M.; Vandenberghe R.; De Deyn P.P.; Van Broeckhoven C.; Sleegers K.; Mutations in ABCA7 in a Belgian cohort of Alzheimer\u2019s disease patients: a targeted resequencing study. Lancet Neurol 2015,14(8),814-822","journal-title":"Lancet Neurol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","volume":"72","author":"Korvatska O.","year":"2015","unstructured":"Korvatska O.; Leverenz J.B.; Jayadev S.; McMillan P.; Kurtz I.; Guo X.; Rumbaugh M.; Matsushita M.; Girirajan S.; Dorschner M.O.; Kiianitsa K.; Yu C.E.; Brkanac Z.; Garden G.A.; Raskind W.H.; Bird T.D.; R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: Clinical, genetic, and neuropathological study. JAMA Neurol 2015,72(8),920-927","journal-title":"JAMA Neurol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ana.24466","volume":"78","author":"Vardarajan B.N.","year":"2015","unstructured":"Vardarajan B.N.; Ghani M.; Kahn A.; Sheikh S.; Sato C.; Barral S.; Lee J.H.; Cheng R.; Reitz C.; Lantigua R.; Reyes-Dumeyer D.; Medrano M.; Jimenez-Velazquez I.Z.; Rogaeva E.; St George-Hyslop P.; Mayeux R.; Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci. Ann Neurol 2015,78(3),487-498","journal-title":"Ann Neurol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"Jonsson T.","year":"2012","unstructured":"Jonsson T.; Atwal J.K.; Steinberg S.; Snaedal J.; Jonsson P.V.; Bjornsson S.; Stefansson H.; Sulem P.; Gudbjartsson D.; Maloney J.; Hoyte K.; Gustafson A.; Liu Y.; Lu Y.; Bhangale T.; Graham R.R.; Huttenlocher J.; Bjornsdottir G.; Andreassen O.A.; J\u00f6nsson E.G.; Palotie A.; Behrens T.W.; Magnusson O.T.; Kong A.; Thorsteinsdottir U.; Watts R.J.; Stefansson K.; A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 2012,488(7409),96-99","journal-title":"Nature"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/mp.2015.131","volume":"20","author":"Lalli M.A.","year":"2015","unstructured":"Lalli M.A.; Bettcher B.M.; Arcila M.L.; Garcia G.; Guzman C.; Madrigal L.; Ramirez L.; Acosta-Uribe J.; Baena A.; Wojta K.J.; Coppola G.; Fitch R.; de Both M.D.; Huentelman M.J.; Reiman E.M.; Brunkow M.E.; Glusman G.; Roach J.C.; Kao A.W.; Lopera F.; Kosik K.S.; Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer\u2019s disease. Mol Psychiatry 2015,20(11),1294-1300","journal-title":"Mol Psychiatry"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1042\/BST0390910","volume":"39","author":"Guerreiro R.J.","year":"2011","unstructured":"Guerreiro R.J.; Hardy J.; Alzheimer\u2019s disease genetics: lessons to improve disease modelling. Biochem Soc Trans 2011,39(4),910-916","journal-title":"Biochem Soc Trans"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2013.10.037","volume":"155","author":"Guerreiro R.","year":"2013","unstructured":"Guerreiro R.; Br\u00e1s J.; Hardy J.; SnapShot: genetics of Alzheimer\u2019s disease. Cell 2013,155(4),968","journal-title":"Cell"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/188255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188255\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/188255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T10:04:27Z","timestamp":1637057067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188255\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566523220666201123112822","relation":{},"ISSN":["1566-5232"],"issn-type":[{"value":"1566-5232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}